JAK Inhibitors and B Cell Function: A Comparative Study of Their Impact on Plasma Cell Differentiation, Cytokine Production, and Naïve B Cell Activation.

Eur J Immunol · 2025 · PMC11914861 · PMID 40098342

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a weak trendno p-value reported

A weak trend for decrease could be seen when using filgotinib at 10 μM, but without reaching statistical significance (Figure 1D ).

also in 327 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.